{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-211760","form_type":"8-K","ticker":"MDGL","cik":"0001157601","company_name":"MADRIGAL PHARMACEUTICALS, INC.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.092460+00:00","generated_at":"2026-06-24T03:44:21.662502+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Madrigal on track for MAESTRO-NASH topline data in Q4 2022; Q2 cash $211.8M","bullets":["Topline data from Phase 3 MAESTRO-NASH biopsy study expected in Q4 2022; NDA filing planned for H1 2023.","Cash, cash equivalents and marketable securities of $211.8M as of June 30, 2022, down from $270.3M at Dec 31, 2021.","Q2 2022 operating expenses $70.3M (R&D $58.5M, G&A $11.8M) vs $61.7M in Q2 2021.","Expanded market development activities; payer education sessions covering >80% of U.S. branded prescriptions.","Plans to initiate MAESTRO-NASH Outcomes study in ~700 early NASH cirrhosis patients for full approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-211760","json":"https://secwatch.observer/filing/0001193125-22-211760.json","markdown":"https://secwatch.observer/filing/0001193125-22-211760.md","text":"https://secwatch.observer/filing/0001193125-22-211760.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157601/000119312522211760/0001193125-22-211760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157601/000119312522211760/d370174d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:44:21.662502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}